DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
MDX-1342
1
Antibody
Investigational
Unknown
Unknown
Arthritis, Rheumatoid; Leukemia, Lymphocytic, Chronic, B-Cell
B-lymphocyte antigen CD19 binding agent
MDX-1342
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
HYDROXYNORKETAMINE, (2R,6R)
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
HYDROXYNORKETAMINE, (2R,6R)
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C12H14ClNO2
Molecular Weight:
239.7
AlogP:
1.61
PSA:
63.32
HBD:
2.0
HBA:
#RotB:
1.0
Source:
CALMANGAFODIPIR
1
Unknown
Investigational
Unknown
Unknown
Peripheral Nervous System Diseases
Unknown
CALMANGAFODIPIR
×
Maximum Phase:
1
First Approval:
None
UNII:
N0JZU0WGU5
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RG7185
1
Small molecule
Investigational
Unknown
Unknown
Unknown
G protein-coupled receptor 44 antagonist
RG7185
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SELITRECTINIB
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Neurotrophic tyrosine kinase receptor inhibitor
SELITRECTINIB
×
Maximum Phase:
1
First Approval:
None
UNII:
0J45910S3X
Molecule Type:
Small molecule
Molecular Formula:
C20H21FN6O
Molecular Weight:
380.43
AlogP:
2.67
PSA:
75.42
HBD:
1.0
HBA:
#RotB:
0.0
Source:
INDIGOTINDISULFONATE
1
Small molecule
Investigational
Unknown
Unknown
Brain Neoplasms
Unknown
INDIGOTINDISULFONATE
×
Maximum Phase:
1
First Approval:
None
UNII:
X7OI7JF73P
Molecule Type:
Small molecule
Molecular Formula:
C16H10N2O8S2
Molecular Weight:
422.4
AlogP:
1.31
PSA:
166.94
HBD:
4.0
HBA:
#RotB:
2.0
Source:
ASP1235
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
ASP1235
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BALAFILCON A
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BALAFILCON A
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LY404039
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Metabotropic glutamate receptor 2 agonist
LY404039
×
Maximum Phase:
1
First Approval:
None
UNII:
531QUG7P9E
Molecule Type:
Small molecule
Molecular Formula:
C7H9NO6S
Molecular Weight:
235.22
AlogP:
-2.1
PSA:
134.76
HBD:
3.0
HBA:
#RotB:
2.0
Source:
PEMLIMOGENE MEROLISBAC
1
Gene
Investigational
Unknown
Unknown
Adenocarcinoma of Lung; Carcinoma, Non-Small-Cell Lung
Unknown
PEMLIMOGENE MEROLISBAC
×
Maximum Phase:
1
First Approval:
None
UNII:
S2EGO8116S
Molecule Type:
Gene
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BTA-9881
1
Small molecule
Investigational
Unknown
Unknown
Respiratory Syncytial Virus Infections
Unknown
BTA-9881
×
Maximum Phase:
1
First Approval:
None
UNII:
9VR1J6U4XG
Molecule Type:
Small molecule
Molecular Formula:
C21H15ClN4O2
Molecular Weight:
390.83
AlogP:
2.94
PSA:
66.4
HBD:
0.0
HBA:
#RotB:
2.0
Source:
ABT-107
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Neuronal acetylcholine receptor protein alpha-7 subunit agonist
ABT-107
×
Maximum Phase:
1
First Approval:
None
UNII:
SXS38HR98H
Molecule Type:
Small molecule
Molecular Formula:
C19H20N4O
Molecular Weight:
320.4
AlogP:
3.1
PSA:
54.04
HBD:
1.0
HBA:
#RotB:
3.0
Source:
TAK-573
1
Unknown
Investigational
Unknown
Unknown
Melanoma; Multiple Myeloma
Unknown
TAK-573
×
Maximum Phase:
1
First Approval:
None
UNII:
TN8CEX4UT2
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PEGTIBATINASE
1
Enzyme
Investigational
Unknown
Unknown
Homocystinuria
Unknown
PEGTIBATINASE
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Enzyme
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
UNESBULIN
1
Small molecule
Investigational
Unknown
Unknown
Diffuse Intrinsic Pontine Glioma; Leiomyosarcoma; Neoplasms; Ovarian Neoplasms
Unknown
UNESBULIN
×
Maximum Phase:
1
First Approval:
None
UNII:
Z4HZ70S62Q
Molecule Type:
Small molecule
Molecular Formula:
C19H13F5N6
Molecular Weight:
420.35
AlogP:
4.75
PSA:
81.65
HBD:
2.0
HBA:
#RotB:
3.0
Source:
REBAUDIOSIDE A
1
Oligosaccharide
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Unknown
REBAUDIOSIDE A
×
Maximum Phase:
1
First Approval:
None
UNII:
B3FUD0528F
Molecule Type:
Oligosaccharide
Molecular Formula:
C44H70O23
Molecular Weight:
967.02
AlogP:
-5.11
PSA:
374.13
HBD:
14.0
HBA:
#RotB:
12.0
Source:
KHK-2866
1
Antibody
Investigational
Unknown
Unknown
Fallopian Tube Neoplasms; Ovarian Neoplasms; Peritoneal Neoplasms
Proheparin-binding EGF-like growth factor inhibitor
KHK-2866
×
Maximum Phase:
1
First Approval:
None
UNII:
111EN0IJ7C
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NARATUXIMAB EMTANSINE
1
Antibody
Investigational
Unknown
Unknown
Leukemia, Lymphocytic, Chronic, B-Cell
Leukocyte antigen CD37 binding agent
NARATUXIMAB EMTANSINE
×
Maximum Phase:
1
First Approval:
None
UNII:
WE1X5A83B9
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DELANZOMIB
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma, Non-Hodgkin; Multiple Myeloma
Unknown
DELANZOMIB
×
Maximum Phase:
1
First Approval:
None
UNII:
6IF28942WO
Molecule Type:
Small molecule
Molecular Formula:
C21H28BN3O5
Molecular Weight:
413.28
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
BMS-986166
1
Small molecule
Investigational
Unknown
Unknown
Colitis, Ulcerative
Unknown
BMS-986166
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C25H33NO2
Molecular Weight:
379.54
AlogP:
4.39
PSA:
55.48
HBD:
2.0
HBA:
#RotB:
6.0
Source:
CAGRILINTIDE
1
Protein
Investigational
Unknown
Unknown
Obesity
Unknown
CAGRILINTIDE
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MITAZALIMAB
1
Antibody
Investigational
Unknown
Unknown
Carcinoma, Pancreatic Ductal; Neoplasms
Unknown
MITAZALIMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
Q9J81E7VFM
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GSK-369796
1
Small molecule
Investigational
Unknown
Unknown
Malaria
Unknown
GSK-369796
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C20H22ClN3O
Molecular Weight:
355.87
AlogP:
5.23
PSA:
57.18
HBD:
3.0
HBA:
#RotB:
4.0
Source:
TIBULIZUMAB
1
Antibody
Investigational
Unknown
Unknown
Arthritis, Rheumatoid; Sjogren's Syndrome
Interleukin 17A inhibitor
TIBULIZUMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
42HQ15W1ZF
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BI113823
1
Small molecule
Investigational
Unknown
Unknown
Osteoarthritis
Bradykinin B1 receptor antagonist
BI113823
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
REGN4659
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
REGN4659
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SIMOTAXEL
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
SIMOTAXEL
×
Maximum Phase:
1
First Approval:
None
UNII:
E1M30YOE59
Molecule Type:
Small molecule
Molecular Formula:
C46H57NO15S
Molecular Weight:
896.02
AlogP:
4.67
PSA:
230.52
HBD:
4.0
HBA:
#RotB:
11.0
Source:
ALEPLASININ
1
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease
Plasminogen activator inhibitor-1 inhibitor
ALEPLASININ
×
Maximum Phase:
1
First Approval:
None
UNII:
LL56J87F3X
Molecule Type:
Small molecule
Molecular Formula:
C28H27NO3
Molecular Weight:
425.53
AlogP:
6.23
PSA:
59.3
HBD:
1.0
HBA:
#RotB:
5.0
Source:
INCAGN-02385
1
Unknown
Investigational
Unknown
Unknown
Melanoma
Unknown
INCAGN-02385
×
Maximum Phase:
1
First Approval:
None
UNII:
Z0A08C63DF
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
E7107
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
E7107
×
Maximum Phase:
1
First Approval:
None
UNII:
R60DZX1E2N
Molecule Type:
Small molecule
Molecular Formula:
C40H66N2O9
Molecular Weight:
718.97
AlogP:
5.05
PSA:
152.53
HBD:
4.0
HBA:
#RotB:
10.0
Source:
BMS-794833
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Hepatocyte growth factor receptor inhibitor
BMS-794833
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SALVINORIN A
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
SALVINORIN A
×
Maximum Phase:
1
First Approval:
None
UNII:
T56W91NG6J
Molecule Type:
Small molecule
Molecular Formula:
C23H28O8
Molecular Weight:
432.47
AlogP:
3.0
PSA:
109.11
HBD:
0.0
HBA:
#RotB:
3.0
Source:
LY-3200882
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
LY-3200882
×
Maximum Phase:
1
First Approval:
None
UNII:
19HY34R6UN
Molecule Type:
Small molecule
Molecular Formula:
C24H29N5O3
Molecular Weight:
435.53
AlogP:
4.67
PSA:
94.32
HBD:
2.0
HBA:
#RotB:
7.0
Source:
PTI-6D2
1
Antibody
Investigational
Unknown
Unknown
Melanoma
Melanin binding agent
PTI-6D2
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CO-ZIDOCAPT
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CO-ZIDOCAPT
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C16H23ClN4O7S3
Molecular Weight:
515.04
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
1
2
…
72
73
74
75
76
77
78
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA